Northern Trust Corp Has $11.16 Million Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

Northern Trust Corp boosted its holdings in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 11.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,172,265 shares of the company's stock after purchasing an additional 116,981 shares during the quarter. Northern Trust Corp owned about 0.87% of AdaptHealth worth $11,160,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Pacer Advisors Inc. acquired a new stake in shares of AdaptHealth in the 4th quarter worth $76,271,000. Principal Financial Group Inc. increased its stake in shares of AdaptHealth by 204.0% during the 4th quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company's stock worth $15,735,000 after purchasing an additional 1,109,021 shares in the last quarter. Segall Bryant & Hamill LLC lifted its position in shares of AdaptHealth by 29.8% in the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock valued at $45,734,000 after acquiring an additional 1,102,173 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of AdaptHealth by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock worth $32,174,000 after buying an additional 505,180 shares in the last quarter. Finally, Royce & Associates LP lifted its position in AdaptHealth by 29.0% during the fourth quarter. Royce & Associates LP now owns 1,002,755 shares of the company's stock worth $9,546,000 after buying an additional 225,350 shares during the period. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Stock Performance

AHCO stock traded up $0.26 on Tuesday, reaching $9.25. 827,033 shares of the company were exchanged, compared to its average volume of 1,278,330. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm has a market capitalization of $1.25 billion, a PE ratio of -5.61, a PEG ratio of 1.08 and a beta of 1.64. The stock's fifty day moving average price is $9.13 and its 200 day moving average price is $9.66.

Analyst Ratings Changes

AHCO has been the topic of a number of research reports. Truist Financial cut their target price on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research note on Monday, May 12th. Royal Bank of Canada dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. UBS Group lowered their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Canaccord Genuity Group boosted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Finally, Robert W. Baird upped their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. Five analysts have rated the stock with a buy rating, According to MarketBeat, AdaptHealth currently has a consensus rating of "Buy" and an average price target of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.